| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | IMP dehydrogenase activity | 4.67e-05 | 2 | 137 | 2 | GO:0003938 | |
| GeneOntologyMolecularFunction | potassium ion leak channel activity | 1.66e-04 | 16 | 137 | 3 | GO:0022841 | |
| GeneOntologyMolecularFunction | potassium channel activity | 2.55e-04 | 128 | 137 | 6 | GO:0005267 | |
| GeneOntologyMolecularFunction | narrow pore channel activity | 2.82e-04 | 19 | 137 | 3 | GO:0022842 | |
| GeneOntologyMolecularFunction | leak channel activity | 2.82e-04 | 19 | 137 | 3 | GO:0022840 | |
| GeneOntologyBiologicalProcess | epithelium development | SOX4 WHRN PRKD2 FLNA SHROOM3 GAK LAMA1 E2F7 EPB41L5 LAMA5 TRIM71 LHX3 KRT79 MEOX1 NFATC4 GLI3 DCHS1 B9D1 UPK3A DMBT1 CSMD1 CDC42 ADAMTSL4 PCK2 FOXF1 NOTCH4 SMAD7 | 1.15e-06 | 1469 | 137 | 27 | GO:0060429 |
| GeneOntologyBiologicalProcess | epithelial cell differentiation | SOX4 WHRN FLNA SHROOM3 GAK LAMA1 E2F7 EPB41L5 LHX3 KRT79 B9D1 UPK3A DMBT1 CDC42 ADAMTSL4 PCK2 FOXF1 NOTCH4 | 1.87e-05 | 870 | 137 | 18 | GO:0030855 |
| GeneOntologyBiologicalProcess | tissue morphogenesis | PRKD2 FLNA SHROOM3 LAMA1 EPB41L5 LAMA5 TRIM71 NFATC4 GLI3 DCHS1 PRKAR1A CSMD1 CDC42 FOXF1 NOTCH4 SMAD7 | 3.92e-05 | 750 | 137 | 16 | GO:0048729 |
| GeneOntologyBiologicalProcess | branching morphogenesis of an epithelial tube | 5.44e-05 | 198 | 137 | 8 | GO:0048754 | |
| GeneOntologyBiologicalProcess | morphogenesis of a branching structure | 5.81e-05 | 258 | 137 | 9 | GO:0001763 | |
| GeneOntologyBiologicalProcess | morphogenesis of an epithelium | PRKD2 FLNA SHROOM3 LAMA1 EPB41L5 LAMA5 TRIM71 NFATC4 GLI3 DCHS1 CSMD1 CDC42 FOXF1 NOTCH4 | 6.61e-05 | 619 | 137 | 14 | GO:0002009 |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | SOX4 WHRN FLNA GAK CDX4 DSCAM SOBP LAMA1 LAMA5 NBL1 LHX3 ACAN GLI3 DCHS1 PRKAR1A PRKAR1B ROM1 CSMD1 CDC42 FOXF1 SMAD7 | 9.61e-05 | 1269 | 137 | 21 | GO:0009887 |
| GeneOntologyBiologicalProcess | epithelial tube morphogenesis | PRKD2 SHROOM3 LAMA1 LAMA5 TRIM71 NFATC4 GLI3 DCHS1 CSMD1 FOXF1 NOTCH4 | 1.19e-04 | 421 | 137 | 11 | GO:0060562 |
| GeneOntologyBiologicalProcess | morphogenesis of a polarized epithelium | 1.26e-04 | 73 | 137 | 5 | GO:0001738 | |
| GeneOntologyBiologicalProcess | regulation of establishment of protein localization | SOX4 FLNA ANK3 EPB41L5 CEP192 ACVR1C CEMIP OXCT1 SLC16A1 GLI3 SLC35D3 PRKAR1A CDC42 PCK2 | 1.62e-04 | 674 | 137 | 14 | GO:0070201 |
| GeneOntologyBiologicalProcess | potassium ion transmembrane transport | 1.63e-04 | 232 | 137 | 8 | GO:0071805 | |
| GeneOntologyBiologicalProcess | stabilization of membrane potential | 1.82e-04 | 17 | 137 | 3 | GO:0030322 | |
| GeneOntologyBiologicalProcess | morphogenesis of a branching epithelium | 1.84e-04 | 236 | 137 | 8 | GO:0061138 | |
| GeneOntologyBiologicalProcess | mesenchyme development | SOX4 FLNA EPB41L5 LAMA5 MEOX1 DCHS1 CDC42 FOXF1 NOTCH4 SMAD7 | 1.95e-04 | 372 | 137 | 10 | GO:0060485 |
| GeneOntologyBiologicalProcess | cell-cell adhesion | SOX4 FLNA ANK3 DSCAM F2RL3 EPB41L5 ACTL6A ADGRV1 PTPRU NPHP4 HMCN1 GLI3 DCHS1 PRKAR1A CDC42 FOXF1 NOTCH4 SMAD7 | 2.82e-04 | 1077 | 137 | 18 | GO:0098609 |
| GeneOntologyBiologicalProcess | anatomical structure formation involved in morphogenesis | WHRN PRKD2 FLNA FLNC KRT8 SHROOM3 DSCAM CAPN3 E2F7 EPB41L5 TRIM71 ACTL6A MEOX1 FIG4 NFATC4 GLI3 DCHS1 PRKAR1A EMC10 CDC42 FOXF1 NOTCH4 | 3.07e-04 | 1483 | 137 | 22 | GO:0048646 |
| GeneOntologyBiologicalProcess | regulation of protein localization | SOX4 FLNA ANK3 EPB41L5 CEP192 ACVR1C HNRNPK GSN CEMIP OXCT1 SLC16A1 GLI3 SLC35D3 PRKAR1A B9D1 CDC42 PCK2 NOTCH4 | 3.15e-04 | 1087 | 137 | 18 | GO:0032880 |
| GeneOntologyBiologicalProcess | establishment of epithelial cell apical/basal polarity | 3.49e-04 | 21 | 137 | 3 | GO:0045198 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | WHRN FLNA SHROOM3 ANK3 DSCAM LAMA1 EPB41L5 LAMA5 NBL1 LHX3 HNRNPK STRIP1 SHROOM1 NFATC4 GLI3 UPK3A CDC42 MOV10 NOTCH4 | 3.49e-04 | 1194 | 137 | 19 | GO:0000902 |
| GeneOntologyBiologicalProcess | neuroepithelial cell differentiation | 3.65e-04 | 51 | 137 | 4 | GO:0060563 | |
| GeneOntologyBiologicalProcess | positive regulation of establishment of protein localization | 3.68e-04 | 403 | 137 | 10 | GO:1904951 | |
| GeneOntologyCellularComponent | cell-cell junction | FLNA KRT8 SHROOM3 ANK3 FRMPD2 LAMA1 EPB41L5 MAGI3 PTPRU NPHP4 GSN SHROOM1 HMCN1 CDC42 SMAD7 PDZD2 | 2.28e-06 | 591 | 140 | 16 | GO:0005911 |
| GeneOntologyCellularComponent | anchoring junction | FLNA FLNC KRT8 SHROOM3 GAK ANK3 FRMPD2 LAMA1 EPB41L5 MAGI3 PTPRU NPHP4 HNRNPK GSN SHROOM1 HMCN1 CDC42 TNS1 SMAD7 PDZD2 | 8.10e-06 | 976 | 140 | 20 | GO:0070161 |
| GeneOntologyCellularComponent | USH2 complex | 2.65e-04 | 4 | 140 | 2 | GO:1990696 | |
| GeneOntologyCellularComponent | costamere | 4.12e-04 | 22 | 140 | 3 | GO:0043034 | |
| GeneOntologyCellularComponent | ciliary base | 5.40e-04 | 56 | 140 | 4 | GO:0097546 | |
| GeneOntologyCellularComponent | stereocilia ankle link | 6.56e-04 | 6 | 140 | 2 | GO:0002141 | |
| GeneOntologyCellularComponent | stereocilia ankle link complex | 6.56e-04 | 6 | 140 | 2 | GO:0002142 | |
| GeneOntologyCellularComponent | periciliary membrane compartment | 6.56e-04 | 6 | 140 | 2 | GO:1990075 | |
| GeneOntologyCellularComponent | apical junction complex | 6.92e-04 | 158 | 140 | 6 | GO:0043296 | |
| GeneOntologyCellularComponent | pericentriolar material | 8.52e-04 | 28 | 140 | 3 | GO:0000242 | |
| GeneOntologyCellularComponent | stereocilia coupling link | 1.21e-03 | 8 | 140 | 2 | GO:0002139 | |
| Domain | Pectin_lyase_fold/virulence | 2.20e-05 | 8 | 139 | 3 | IPR011050 | |
| Domain | IG_FLMN | 4.66e-05 | 10 | 139 | 3 | SM00557 | |
| Domain | IMP_DH | 5.50e-05 | 2 | 139 | 2 | IPR005990 | |
| Domain | Gamma_tubulin | 5.50e-05 | 2 | 139 | 2 | IPR002454 | |
| Domain | Filamin | 6.37e-05 | 11 | 139 | 3 | PF00630 | |
| Domain | FILAMIN_REPEAT | 6.37e-05 | 11 | 139 | 3 | PS50194 | |
| Domain | Filamin/ABP280_rpt | 6.37e-05 | 11 | 139 | 3 | IPR001298 | |
| Domain | Filamin/ABP280_repeat-like | 6.37e-05 | 11 | 139 | 3 | IPR017868 | |
| Domain | 2pore_dom_K_chnl_TWIK | 1.64e-04 | 3 | 139 | 2 | IPR005408 | |
| Domain | ASD1 | 1.64e-04 | 3 | 139 | 2 | PF08688 | |
| Domain | ASD1_dom | 1.64e-04 | 3 | 139 | 2 | IPR014800 | |
| Domain | ASD1 | 1.64e-04 | 3 | 139 | 2 | PS51306 | |
| Domain | 2pore_dom_K_chnl | 1.72e-04 | 15 | 139 | 3 | IPR003280 | |
| Domain | IMPDH | 3.27e-04 | 4 | 139 | 2 | PF00478 | |
| Domain | G8_domain | 3.27e-04 | 4 | 139 | 2 | IPR019316 | |
| Domain | G8 | 3.27e-04 | 4 | 139 | 2 | PS51484 | |
| Domain | IMP_DH_GMPRt | 3.27e-04 | 4 | 139 | 2 | IPR001093 | |
| Domain | Shroom_fam | 3.27e-04 | 4 | 139 | 2 | IPR027685 | |
| Domain | cAMP_dep_PK_reg_su | 3.27e-04 | 4 | 139 | 2 | IPR012198 | |
| Domain | IMP_DH_GMP_RED | 3.27e-04 | 4 | 139 | 2 | PS00487 | |
| Domain | IMP_DH/GMP_Rdtase_CS | 3.27e-04 | 4 | 139 | 2 | IPR015875 | |
| Domain | G8 | 3.27e-04 | 4 | 139 | 2 | SM01225 | |
| Domain | ASD2_dom | 3.27e-04 | 4 | 139 | 2 | IPR014799 | |
| Domain | ASD2 | 3.27e-04 | 4 | 139 | 2 | PF08687 | |
| Domain | G8 | 3.27e-04 | 4 | 139 | 2 | PF10162 | |
| Domain | ASD2 | 3.27e-04 | 4 | 139 | 2 | PS51307 | |
| Domain | K_chnl_dom | 4.86e-04 | 21 | 139 | 3 | IPR013099 | |
| Domain | Ion_trans_2 | 4.86e-04 | 21 | 139 | 3 | PF07885 | |
| Domain | Laminin_domII | 5.42e-04 | 5 | 139 | 2 | IPR010307 | |
| Domain | Laminin_aI | 5.42e-04 | 5 | 139 | 2 | IPR009254 | |
| Domain | Laminin_I | 5.42e-04 | 5 | 139 | 2 | PF06008 | |
| Domain | Laminin_II | 5.42e-04 | 5 | 139 | 2 | PF06009 | |
| Domain | Pectin_lyas_fold | 8.09e-04 | 6 | 139 | 2 | IPR012334 | |
| Domain | PbH1 | 8.09e-04 | 6 | 139 | 2 | SM00710 | |
| Domain | - | 8.09e-04 | 6 | 139 | 2 | 2.160.20.10 | |
| Domain | RIIa | 8.09e-04 | 6 | 139 | 2 | SM00394 | |
| Domain | PbH1 | 8.09e-04 | 6 | 139 | 2 | IPR006626 | |
| Domain | Ig_E-set | 1.08e-03 | 104 | 139 | 5 | IPR014756 | |
| Domain | RIIa | 1.13e-03 | 7 | 139 | 2 | PF02197 | |
| Domain | PTEN_C2 | 1.50e-03 | 8 | 139 | 2 | PF10409 | |
| Domain | PTEN_C2 | 1.50e-03 | 8 | 139 | 2 | SM01326 | |
| Domain | C2_TENSIN | 1.50e-03 | 8 | 139 | 2 | PS51182 | |
| Domain | Tensin_lipid_phosphatase_dom | 1.50e-03 | 8 | 139 | 2 | IPR029023 | |
| Domain | LAMININ_IVA | 1.50e-03 | 8 | 139 | 2 | PS51115 | |
| Domain | Laminin_B | 1.50e-03 | 8 | 139 | 2 | PF00052 | |
| Domain | Tensin_C2-dom | 1.50e-03 | 8 | 139 | 2 | IPR014020 | |
| Domain | LamB | 1.50e-03 | 8 | 139 | 2 | SM00281 | |
| Domain | Laminin_IV | 1.50e-03 | 8 | 139 | 2 | IPR000034 | |
| Domain | PPASE_TENSIN | 1.91e-03 | 9 | 139 | 2 | PS51181 | |
| Domain | 2pore_dom_K_chnl_TASK | 1.91e-03 | 9 | 139 | 2 | IPR003092 | |
| Domain | GPS | 2.04e-03 | 34 | 139 | 3 | SM00303 | |
| Domain | GPS | 2.22e-03 | 35 | 139 | 3 | PF01825 | |
| Domain | GPS | 2.41e-03 | 36 | 139 | 3 | PS50221 | |
| Domain | GPS | 2.60e-03 | 37 | 139 | 3 | IPR000203 | |
| Pathway | WP_NPHP1_DELETION_SYNDROME | 6.90e-05 | 11 | 108 | 3 | M48099 | |
| Pathway | REACTOME_TANDEM_PORE_DOMAIN_POTASSIUM_CHANNELS | 6.90e-05 | 11 | 108 | 3 | MM14547 | |
| Pathway | REACTOME_TANDEM_PORE_DOMAIN_POTASSIUM_CHANNELS | 9.15e-05 | 12 | 108 | 3 | M1071 | |
| Pubmed | Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways. | FLNA FLNC DPYSL2 KRT8 IMPDH1 CDK12 SOBP EPB41L5 KRT79 NPHP4 GSN PLEKHG1 OXCT1 GLI3 B9D1 | 1.10e-08 | 564 | 141 | 15 | 21565611 |
| Pubmed | NCOA2 DPYSL2 SHROOM3 IMPDH2 ANK3 DSCAM WDR7 HNRNPK GSN STRIP1 SLC7A3 KCNA4 ZC3H4 DCHS1 PRKAR1A PRKAR1B KCNAB1 TNS1 | 7.81e-08 | 963 | 141 | 18 | 28671696 | |
| Pubmed | WHRN WDR7 TSPOAP1 AVL9 PPRC1 CEP192 STRIP1 PLEKHG1 RHOBTB2 KATNIP MCF2L PDZD2 | 1.15e-07 | 407 | 141 | 12 | 12693553 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | FLNC DPYSL2 KRT8 IMPDH2 WDR7 CDK12 TRIM71 PRPF6 ACTL6A AGPS TUBG1 HNRNPK TBC1D10B SF3B3 SLC16A1 ZC3H4 DYNC1LI1 CATSPERG | 4.31e-07 | 1082 | 141 | 18 | 38697112 |
| Pubmed | 4.54e-07 | 16 | 141 | 4 | 30579834 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | SOX4 PRKD2 FLNA FLNC SHROOM3 IMPDH1 PPRC1 CDK12 LAMA5 NBL1 CEP192 NPHP4 TUBG1 TBC1D16 PLEKHG1 MCF2L RGL2 SMAD7 | 5.84e-07 | 1105 | 141 | 18 | 35748872 |
| Pubmed | 6.48e-07 | 5 | 141 | 3 | 12006559 | ||
| Pubmed | Mutations in the Heterotopia Gene Eml1/EML1 Severely Disrupt the Formation of Primary Cilia. | 6.48e-07 | 5 | 141 | 3 | 31390572 | |
| Pubmed | FLNA FLNC KRT8 ANK3 MIDEAS HNRNPK MSL2 PRKAR1A PRKAR1B CDC42 RGL2 TNS1 | 7.58e-07 | 486 | 141 | 12 | 20936779 | |
| Pubmed | Disruption of a ciliary B9 protein complex causes Meckel syndrome. | 7.58e-07 | 18 | 141 | 4 | 21763481 | |
| Pubmed | 9.57e-07 | 19 | 141 | 4 | 16061793 | ||
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | FLNA FLNC DPYSL2 KRT8 IMPDH2 ANK3 CDK12 PRPF6 ACTL6A TUBG1 HNRNPK GSN SF3B3 ZC3H4 PRKAR1A DYNC1LI1 CDC42 MOV10 | 1.02e-06 | 1149 | 141 | 18 | 35446349 |
| Pubmed | 1.29e-06 | 6 | 141 | 3 | 15668394 | ||
| Pubmed | TMEM216 promotes primary ciliogenesis and Hedgehog signaling through the SUFU-GLI2/GLI3 axis. | 2.26e-06 | 7 | 141 | 3 | 38261656 | |
| Pubmed | 2.32e-06 | 360 | 141 | 10 | 33111431 | ||
| Pubmed | 3.60e-06 | 8 | 141 | 3 | 26540106 | ||
| Pubmed | 3.60e-06 | 8 | 141 | 3 | 32439764 | ||
| Pubmed | The small GTPase RSG1 controls a final step in primary cilia initiation. | 4.91e-06 | 28 | 141 | 4 | 29038301 | |
| Pubmed | RNF169 IMPDH1 UBE2Q1 CENPC FKBP9 ACTL6A TUBG1 CASKIN2 PRKAR1A B9D1 CATSPERG PCK2 FOXF1 | 5.03e-06 | 689 | 141 | 13 | 36543142 | |
| Pubmed | Centriolar Protein C2cd3 Is Required for Craniofacial Development. | 5.38e-06 | 9 | 141 | 3 | 34211969 | |
| Pubmed | 5.38e-06 | 9 | 141 | 3 | 15102706 | ||
| Pubmed | Laminin γ1 C-terminal Glu to Gln mutation induces early postimplantation lethality. | 5.38e-06 | 9 | 141 | 3 | 30456378 | |
| Pubmed | 7.48e-06 | 31 | 141 | 4 | 22282597 | ||
| Pubmed | 7.67e-06 | 10 | 141 | 3 | 22911783 | ||
| Pubmed | 7.67e-06 | 10 | 141 | 3 | 20592197 | ||
| Pubmed | A role for primary cilia in aortic valve development and disease. | 7.67e-06 | 10 | 141 | 3 | 28556366 | |
| Pubmed | 1.05e-05 | 11 | 141 | 3 | 37776236 | ||
| Pubmed | 1.40e-05 | 12 | 141 | 3 | 28069795 | ||
| Pubmed | Potassium leak channels and the KCNK family of two-P-domain subunits. | 1.40e-05 | 12 | 141 | 3 | 11256078 | |
| Pubmed | 1.40e-05 | 12 | 141 | 3 | 16750824 | ||
| Pubmed | 1.63e-05 | 272 | 141 | 8 | 31010829 | ||
| Pubmed | Mass Spectrometry and Computer Simulation Predict the Interactions of AGPS and HNRNPK in Glioma. | 1.63e-05 | 2 | 141 | 2 | 34621897 | |
| Pubmed | Expression of IMPDH mRNA after mycophenolate administration in male volunteers. | 1.63e-05 | 2 | 141 | 2 | 25105143 | |
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 1448119 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 20718729 | ||
| Pubmed | The laminin response in inflammatory bowel disease: protection or malignancy? | 1.63e-05 | 2 | 141 | 2 | 25347196 | |
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 1969416 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 20019771 | ||
| Pubmed | MTOC reorientation occurs during FcgammaR-mediated phagocytosis in macrophages. | 1.63e-05 | 2 | 141 | 2 | 17442887 | |
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 34051020 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 16188468 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 7689010 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 22806905 | ||
| Pubmed | Sites of aggrecan cleavage by recombinant human aggrecanase-1 (ADAMTS-4). | 1.63e-05 | 2 | 141 | 2 | 10751421 | |
| Pubmed | Targeted disruption of the inosine 5'-monophosphate dehydrogenase type I gene in mice. | 1.63e-05 | 2 | 141 | 2 | 12944494 | |
| Pubmed | Release of autoinhibition of ASEF by APC leads to CDC42 activation and tumor suppression. | 1.63e-05 | 2 | 141 | 2 | 17704816 | |
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 10679933 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 17287496 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 2902093 | ||
| Pubmed | Characterization of human type I and type II IMP dehydrogenases. | 1.63e-05 | 2 | 141 | 2 | 7903306 | |
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 7763314 | ||
| Pubmed | A novel structural unit in the N-terminal region of filamins. | 1.63e-05 | 2 | 141 | 2 | 24469451 | |
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 28119396 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 28544784 | ||
| Pubmed | Inosine 5'-monophosphate dehydrogenase binds nucleic acids in vitro and in vivo. | 1.63e-05 | 2 | 141 | 2 | 14766016 | |
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 39014441 | ||
| Pubmed | Characterization of the human inosine-5'-monophosphate dehydrogenase type II gene. | 1.63e-05 | 2 | 141 | 2 | 7896827 | |
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 20679962 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 17713475 | ||
| Pubmed | The contribution of GPR98 and DFNB31 genes to a Spanish Usher syndrome type 2 cohort. | 1.63e-05 | 2 | 141 | 2 | 23441107 | |
| Pubmed | Mutants of purine metabolism in cultured mouse and hamster cells. | 1.63e-05 | 2 | 141 | 2 | 988789 | |
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 23897278 | ||
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 22670872 | ||
| Pubmed | Multifunctional roles for the PH domain of Dbs in regulating Rho GTPase activation. | 1.63e-05 | 2 | 141 | 2 | 12637522 | |
| Pubmed | Gene knockout analysis of two gamma-tubulin isoforms in mice. | 1.63e-05 | 2 | 141 | 2 | 15893303 | |
| Pubmed | 1.63e-05 | 2 | 141 | 2 | 8407966 | ||
| Pubmed | Regulation and related mechanism of GSN mRNA level by hnRNPK in lung adenocarcinoma cells. | 1.63e-05 | 2 | 141 | 2 | 30771276 | |
| Pubmed | FLNA DPYSL2 ANK3 TSPOAP1 TUBG1 SLC6A1 OXCT1 KCNA4 SLC16A1 PRKAR1A DYNC1LI1 PRKAR1B KCNAB1 EMC10 CDC42 PCK2 | 1.64e-05 | 1139 | 141 | 16 | 36417873 | |
| Pubmed | FLNA FLNC IMPDH2 E2F7 PRPF6 ACTL6A HNRNPK SF3B3 ZC3H4 PRKAR1A MOV10 | 1.65e-05 | 551 | 141 | 11 | 34728620 | |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | 1.78e-05 | 361 | 141 | 9 | 26167880 | |
| Pubmed | SHROOM3 ANK3 DSCAM WDR7 EPB41L5 CEP192 AGPS PKHD1L1 HNRNPK STRIP1 ZC3H4 GLI3 CLSPN | 1.80e-05 | 777 | 141 | 13 | 35844135 | |
| Pubmed | 1.81e-05 | 13 | 141 | 3 | 32909945 | ||
| Pubmed | 1.81e-05 | 13 | 141 | 3 | 24853502 | ||
| Pubmed | 1.97e-05 | 202 | 141 | 7 | 24639526 | ||
| Pubmed | 2.30e-05 | 14 | 141 | 3 | 16382106 | ||
| Pubmed | 2.30e-05 | 14 | 141 | 3 | 32151560 | ||
| Pubmed | 2.30e-05 | 14 | 141 | 3 | 19783738 | ||
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | SOX4 WHRN ANK3 RHBDD2 PRPF6 NPHP4 TUBG1 GSN GPBP1L1 SF3B3 GLI3 PRKAR1A B9D1 DYNC1LI1 KATNIP PCK2 MOV10 | 2.69e-05 | 1321 | 141 | 17 | 27173435 |
| Pubmed | Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis. | 2.86e-05 | 15 | 141 | 3 | 23583980 | |
| Pubmed | 2.86e-05 | 15 | 141 | 3 | 21148103 | ||
| Pubmed | Novel gene function revealed by mouse mutagenesis screens for models of age-related disease. | 3.10e-05 | 44 | 141 | 4 | 27534441 | |
| Pubmed | 3.51e-05 | 16 | 141 | 3 | 17601529 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | FLNA FLNC DPYSL2 IMPDH2 CENPC EPB41L5 PRPF6 ACTL6A AGPS MIDEAS HNRNPK SF3B3 OXCT1 SLC16A1 DYNC1LI1 PCK2 MOV10 | 3.63e-05 | 1353 | 141 | 17 | 29467282 |
| Pubmed | Primary Cilia are Required for Cell-Type Determination and Angiogenesis in Pituitary Development. | 4.03e-05 | 47 | 141 | 4 | 39001875 | |
| Pubmed | MicroRNA-140 plays dual roles in both cartilage development and homeostasis. | 4.25e-05 | 17 | 141 | 3 | 20466812 | |
| Pubmed | 4.88e-05 | 3 | 141 | 2 | 14701795 | ||
| Pubmed | 4.88e-05 | 3 | 141 | 2 | 25845235 | ||
| Pubmed | 4.88e-05 | 3 | 141 | 2 | 28031525 | ||
| Pubmed | 4.88e-05 | 3 | 141 | 2 | 11038172 | ||
| Pubmed | T cell activation triggers reversible inosine-5'-monophosphate dehydrogenase assembly. | 4.88e-05 | 3 | 141 | 2 | 30154209 | |
| Pubmed | 4.88e-05 | 3 | 141 | 2 | 10620696 | ||
| Pubmed | 4.88e-05 | 3 | 141 | 2 | 11102480 | ||
| Pubmed | Filamin A negatively regulates the transcriptional activity of p73alpha in the cytoplasm. | 4.88e-05 | 3 | 141 | 2 | 17825253 | |
| Pubmed | Fibulin-2 binds to the short arms of laminin-5 and laminin-1 via conserved amino acid sequences. | 4.88e-05 | 3 | 141 | 2 | 9006922 | |
| Pubmed | 4.88e-05 | 3 | 141 | 2 | 12393796 | ||
| Pubmed | Laminin isoform-specific promotion of adhesion and migration of human bone marrow progenitor cells. | 4.88e-05 | 3 | 141 | 2 | 12393739 | |
| Pubmed | α1- and α5-containing laminins regulate the development of bile ducts via β1 integrin signals. | 4.88e-05 | 3 | 141 | 2 | 22761447 | |
| Pubmed | 4.88e-05 | 3 | 141 | 2 | 3479018 | ||
| Pubmed | 4.88e-05 | 3 | 141 | 2 | 9412467 | ||
| Pubmed | 4.88e-05 | 3 | 141 | 2 | 11153914 | ||
| Interaction | FLNC interactions | 5.30e-06 | 234 | 139 | 10 | int:FLNC | |
| GeneFamily | Potassium two pore domain channel subfamily K | 6.70e-05 | 15 | 98 | 3 | 277 | |
| GeneFamily | Fibronectin type III domain containing|USH2 complex | 1.73e-04 | 4 | 98 | 2 | 1244 | |
| GeneFamily | DNAJ (HSP40) heat shock proteins|C2 tensin-type domain containing | 7.97e-04 | 8 | 98 | 2 | 837 | |
| GeneFamily | PDZ domain containing | 1.43e-03 | 152 | 98 | 5 | 1220 | |
| GeneFamily | Laminin subunits | 1.85e-03 | 12 | 98 | 2 | 626 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 3.05e-03 | 181 | 98 | 5 | 694 | |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_LARGE_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_DN | PRKD2 DPYSL2 IMPDH1 KRT79 PKHD1L1 GSN ABCA6 TNS1 ADAMTSL4 FOXF1 NOTCH4 SMAD7 PDZD2 | 2.67e-06 | 491 | 141 | 13 | MM455 |
| Coexpression | GSE360_L_MAJOR_VS_B_MALAYI_LOW_DOSE_MAC_DN | 1.28e-05 | 199 | 141 | 8 | M5251 | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_nasal_Tgfbr2_WT_2500_K2 | IGSF8 WHRN FLNA FLNC IMPDH1 IMPDH2 ADAMTS4 FKBP9 NBL1 PPIC IVD SLC7A3 TRPM5 TBRG1 HMCN1 NFATC4 DCHS1 PRKAR1B KCNK6 MOV10 OPLAH PDZD2 | 1.57e-05 | 1228 | 139 | 22 | facebase_RNAseq_e14.5_palate_poster_nasal_Tgfbr2_WT_2500_K2 |
| ToppCell | 5'-Adult-SmallIntestine-Endothelial-blood_vessel_EC-arterial_capillary|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | ADAMTS4 F2RL3 LAMA5 GSN PLEKHG1 CASKIN2 MCF2L FOXF1 NOTCH4 SMAD7 | 7.36e-10 | 196 | 141 | 10 | c5fe470f11ee4962bcfb30cddfd8c078af5b1222 |
| ToppCell | Control-Epithelial_cells-ECM-high_epithelial|Control / group, cell type (main and fine annotations) | 3.87e-09 | 170 | 141 | 9 | e2023d66e70983c87dacbd6181d3426488d1fc57 | |
| ToppCell | Control|World / group, cell type (main and fine annotations) | 6.64e-08 | 168 | 141 | 8 | a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.45e-07 | 186 | 141 | 8 | 2ea5ff14861e5f91d0e6a5767c403a24045d715c | |
| ToppCell | COPD-Epithelial-Club|World / Disease state, Lineage and Cell class | 1.45e-07 | 186 | 141 | 8 | 3006f4ab1eaf1eb34c10ca9f7c869603d2d25744 | |
| ToppCell | 5'-Adult-Appendix-Endothelial-blood_vessel_EC-arterial_capillary|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.58e-07 | 188 | 141 | 8 | a11b12f1857953bcdbfb5f25e127f2350c39567d | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.78e-07 | 191 | 141 | 8 | ca5669bd6f4a17471acae3eb229f845cc2e08efa | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|World / Lineage, Cell type, age group and donor | 1.78e-07 | 191 | 141 | 8 | d3733c8c4bda70c4390e5601fdda6188a64be944 | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 2.34e-07 | 198 | 141 | 8 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 2.53e-07 | 200 | 141 | 8 | 032df80aa5c40991e1c1e80f9d8da106e6aeaee2 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN---|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 2.53e-07 | 200 | 141 | 8 | 68fce28690246895fd33354b30960ebcc31aa4cc | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN-|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 2.53e-07 | 200 | 141 | 8 | 376b19ab5a7cd2c85f726d8ba41337d4525863e5 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN--|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 2.53e-07 | 200 | 141 | 8 | 7fa54370221ed61bac0e09e6bcf1f3dff202a846 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN----L2-6|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 2.53e-07 | 200 | 141 | 8 | 878bbbe32e3602723aa14ef32877ab2453b8c6e5 | |
| ToppCell | Hematolymphoid-Endothelial|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 2.53e-07 | 200 | 141 | 8 | 7136936d05ab344a560cf159684c881063b5430d | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.11e-06 | 168 | 141 | 7 | 37249f38f8f04ec5743097259de67b106ca2b02f | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.20e-06 | 170 | 141 | 7 | a2c738e441ced90eeeb1fcc6ca3269b918aaa298 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_bronchial_vessel|Adult / Lineage, Cell type, age group and donor | 1.30e-06 | 172 | 141 | 7 | ad4ffdb3fc0c560a9cbaa2bc048476cbc43e8fd6 | |
| ToppCell | COVID-19-Epithelial_cells-AT1|COVID-19 / group, cell type (main and fine annotations) | 1.69e-06 | 179 | 141 | 7 | a0b33bd69ffdfd5d38d80207fb40058a490aa19e | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.69e-06 | 179 | 141 | 7 | cb38b54261a7af5ee3347e64c8aa880a77ed0763 | |
| ToppCell | 3'-Adult-SmallIntestine-Endothelial-blood_vessel_EC-arterial_capillary|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.76e-06 | 180 | 141 | 7 | efc4c5a4dea456527526bbfd88cf70d803893671 | |
| ToppCell | 3'-Adult-SmallIntestine-Endothelial-blood_vessel_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.96e-06 | 183 | 141 | 7 | 858682df5592c6856487487a7baabd6e60e63a38 | |
| ToppCell | 3'-Adult-SmallIntestine-Endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.96e-06 | 183 | 141 | 7 | f8212bf8a8b8312434ae030261c558c147f61747 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.03e-06 | 184 | 141 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | COVID-19-Epithelial_cells-AT2|COVID-19 / group, cell type (main and fine annotations) | 2.03e-06 | 184 | 141 | 7 | 369b82f793deab672204558ae4e112cfa5aa9ccc | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.03e-06 | 184 | 141 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.03e-06 | 184 | 141 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.11e-06 | 185 | 141 | 7 | 98b8ee42b89d97e4c9db01740e0c193503c68f2c | |
| ToppCell | COVID-19-kidney-FLT1+PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.11e-06 | 185 | 141 | 7 | 673308ca0514a4d3629d61fe91e9d8fb31b72166 | |
| ToppCell | Endothelial-A-Donor_01|World / lung cells shred on cell class, cell subclass, sample id | 2.18e-06 | 186 | 141 | 7 | 796cbae2a417502aaf0891fc9c382bbfd88967fe | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-venous_capillary|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.34e-06 | 188 | 141 | 7 | 0026c9479b30fb39daa91cfa220a88f9c9e65fe7 | |
| ToppCell | COVID-19-Epithelial_cells|COVID-19 / group, cell type (main and fine annotations) | 2.34e-06 | 188 | 141 | 7 | c9cdee6f8d42ee69f5fb335f25084603c511bd29 | |
| ToppCell | Endothelial-A-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 2.34e-06 | 188 | 141 | 7 | 0824d567356d360fd8e78e840c30529c139f98a1 | |
| ToppCell | COVID-19-Heart-EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 2.51e-06 | 190 | 141 | 7 | a21653bfb7bafbc273f94fa7c13bfb48cf8fd562 | |
| ToppCell | LAM-Epithelial-AT1|LAM / Condition, Lineage and Cell class | 2.60e-06 | 191 | 141 | 7 | 66875b2ec2c510489407f3e433a90cdf74a15094 | |
| ToppCell | Control-Epithelial-Club|Control / Disease state, Lineage and Cell class | 2.69e-06 | 192 | 141 | 7 | d84ed1ea4a03edaa18c804f75afb03bd7b1f0e16 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2|World / Lineage, Cell type, age group and donor | 2.69e-06 | 192 | 141 | 7 | 58c3737be7acce39fd2b91d70d6d7b2bbaa4f710 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.69e-06 | 192 | 141 | 7 | 29f49f00770c991b5f27e4cb701dd2d2d6cb7178 | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | 2.69e-06 | 192 | 141 | 7 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.79e-06 | 193 | 141 | 7 | fd4d3c0d7caf8a2fff5b3d901fc28d19a8163cdf | |
| ToppCell | 5'-Adult-Distal_Rectal-Mesenchymal-Pericytes|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.79e-06 | 193 | 141 | 7 | 7631bf3362b4fa061ffeab4879ab12c4708dc4c0 | |
| ToppCell | 5'-Adult-Distal_Rectal-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.79e-06 | 193 | 141 | 7 | 8d15c63f2ae48d0a00d7ef5fdafa917ab8ad0571 | |
| ToppCell | COVID-19-Endothelial_cells-Inflamed_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 2.79e-06 | 193 | 141 | 7 | 979ebefa527f86bebeea5d94e626ee6c1cc7d53b | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.79e-06 | 193 | 141 | 7 | f3cc7cfdbc164a4ed42f87647111522b7d393bcb | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.89e-06 | 194 | 141 | 7 | 53f3e49e91b1096f3226010e2de767efb490dfe4 | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.99e-06 | 195 | 141 | 7 | dccc32fcf772e2504de7f663ef0a5bd8e23e92fc | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 3.09e-06 | 196 | 141 | 7 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | PND10-Mesenchymal|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.09e-06 | 196 | 141 | 7 | ace167a40adb7022b365be3c2b1cbd4ba963739a | |
| ToppCell | Fetal_29-31_weeks-Endothelial|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.09e-06 | 196 | 141 | 7 | 3981f6c7487598f4f7ce4650ac0ac5bd41481d66 | |
| ToppCell | Endothelial|World / Lineage, Cell type, age group and donor | 3.09e-06 | 196 | 141 | 7 | 96c6d78482a130ce4e29f6629972a06d10d7530e | |
| ToppCell | Parenchyma_Control_(B.)-Endothelial-TX-Endothelial-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 3.19e-06 | 197 | 141 | 7 | f969685dee212f33a6f09e54c0cd1fd24ffef546 | |
| ToppCell | Lung_Parenchyma-Control-Endothelial-Endothelial-Endothelial-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.19e-06 | 197 | 141 | 7 | 1a137af40697137bb9d2b5caf2b1ffda55f04461 | |
| ToppCell | myeloid-pro-pDC|World / Lineage and Cell class | 3.19e-06 | 197 | 141 | 7 | 8918ee006b16f6b86ed33ce1dd5c0f01f51f88f5 | |
| ToppCell | Lung_Parenchyma-Control-Endothelial-Endothelial-Endothelial-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.19e-06 | 197 | 141 | 7 | 96d63a8d00583e2aa0a38412e2ae27e23f399493 | |
| ToppCell | Fibroblasts-DKK3+_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 3.30e-06 | 198 | 141 | 7 | 4f4632f26a2043c5e4ab89031b4229b5dca1bd48 | |
| ToppCell | Lung_Parenchyma-Control-Endothelial-Endothelial-Capillary|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.41e-06 | 199 | 141 | 7 | 3fea92affacd4c1f588fa81807df35d6c69b7241 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.41e-06 | 199 | 141 | 7 | 8587bd98de7767a575088afbea07a1feb4516b9b | |
| ToppCell | 5'-Adult-SmallIntestine-Endothelial-blood_vessel_EC-Mature_venous_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.41e-06 | 199 | 141 | 7 | 07bda4ac8ffdce1a865ebc99e46c2a27925ff7a8 | |
| ToppCell | Lung_Parenchyma-Control-Endothelial-Endothelial-Capillary-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.41e-06 | 199 | 141 | 7 | 993999adf346b4fd557989bc53c17eb0ccb996c9 | |
| ToppCell | Parenchymal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.41e-06 | 199 | 141 | 7 | 5cea0d9e261903e0eaad60c28a07dff72ce65027 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.41e-06 | 199 | 141 | 7 | 214a6a267e77e5508867b9eb48c4fbc7855ed0a0 | |
| ToppCell | droplet-Trachea|droplet / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.41e-06 | 199 | 141 | 7 | 1c7d30765ddb2291967da5d15664c6238c680c1d | |
| ToppCell | droplet-Trachea|droplet / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.41e-06 | 199 | 141 | 7 | b9038a1ccf3ef3123e2e39afbe6213c363437443 | |
| ToppCell | Parenchyma_Control_(B.)-Endothelial-TX-Capillary|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 3.41e-06 | 199 | 141 | 7 | 89f4db619fbed90f7fdf6ece7a671e514b5c6d76 | |
| ToppCell | 5'-Adult-LargeIntestine-Endothelial-blood_vessel_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.41e-06 | 199 | 141 | 7 | 258d59cf811bf1668ffbb5f18f961021f660de62 | |
| ToppCell | Parenchymal-10x3prime_v2-Endothelial-Endothelia_vascular-VE_capillary|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.41e-06 | 199 | 141 | 7 | 772b3f60b83e29b958e1e70dadfd9f058ed4cb7c | |
| ToppCell | Parenchymal-10x5prime-Endothelial-Endothelia_vascular-VE_capillary|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.53e-06 | 200 | 141 | 7 | 2d962c9d63e9e5f1a06870e383609672e7b1738c | |
| ToppCell | Parenchymal-10x5prime-Endothelial-Endothelia_vascular|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.53e-06 | 200 | 141 | 7 | 2989325b0e78ab42f362cfb59e34a4fce7f8e869 | |
| ToppCell | Parenchymal-10x5prime-Endothelial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.53e-06 | 200 | 141 | 7 | 0e648e9eb96c83a94505d07323785a7a40997eb0 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.53e-06 | 200 | 141 | 7 | acdef0b9096c774040948fc75621ff2b08ea2ee8 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.53e-06 | 200 | 141 | 7 | 091a18d6efed81cab99955c3047f172170f70476 | |
| ToppCell | Lung_Parenchyma-Control-Endothelial|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.53e-06 | 200 | 141 | 7 | 41ac6adbf61763aa8a81a0ed586c4a5542a42cc5 | |
| ToppCell | Biopsy_Other_PF-Epithelial-Transitional_AT2|Biopsy_Other_PF / Sample group, Lineage and Cell type | 3.53e-06 | 200 | 141 | 7 | 1ba6327851aa61e9a1f1fe1671bc27929d93ac74 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Oligodendrocyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.53e-06 | 200 | 141 | 7 | 3b8513defe25262ab4b492345b2628570eaefd17 | |
| ToppCell | distal-Endothelial-Capillary_Intermediate_1-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.53e-06 | 200 | 141 | 7 | 43bc48413b100a06f8edd9acd812296788fcbf5b | |
| ToppCell | Bronchial-10x5prime-Endothelial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.53e-06 | 200 | 141 | 7 | ad34c978cc6b89b4c1c8c9b2fb2a938051b555a0 | |
| ToppCell | Lung_Parenchyma-Control-Endothelial-Endothelial|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.53e-06 | 200 | 141 | 7 | 5109b417c066ecca0252008206b4f4b7a14c8702 | |
| ToppCell | Parenchymal-10x3prime_v2-Endothelial-Endothelia_vascular|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.53e-06 | 200 | 141 | 7 | 6567683f8f534310fecb44a6721909183fdc15ca | |
| ToppCell | Biopsy_IPF-Endothelial|Biopsy_IPF / Sample group, Lineage and Cell type | 3.53e-06 | 200 | 141 | 7 | 7ccd3b617838b39da814278dc0e12384013401ce | |
| ToppCell | distal-Endothelial-Capillary_Intermediate_1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.53e-06 | 200 | 141 | 7 | 4d6714d48738cdee7d535923f6dd2431e5304741 | |
| ToppCell | Bronchial-10x5prime-Endothelial-Endothelia_vascular|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.53e-06 | 200 | 141 | 7 | 6a3ccd0ea742fa76282c2b0fbc59942b4ef47bb8 | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE-P3|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 9.99e-06 | 90 | 141 | 5 | a0baaf2b3cf07d457f0d242fc213689cba6fd449 | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE-P3-Tnr|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 9.99e-06 | 90 | 141 | 5 | ab4b08c6ac8695b38f841c0ecf2bb2c032111d04 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.17e-05 | 159 | 141 | 6 | 8680b054622f573a82b1625fb93c2d5db81d1034 | |
| ToppCell | 390C-Myeloid-Macrophage-SPP1+_Macrophage_2|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 1.21e-05 | 160 | 141 | 6 | 8aaf6ac4f33ea291387fdbf9ff1a91d559391774 | |
| ToppCell | Frontal_cortex-Macroglia-POLYDENDROCYTE-P2|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.67e-05 | 100 | 141 | 5 | 3a7e5469de88745ac455c35deeb859d68dce73fa | |
| ToppCell | Frontal_cortex-Macroglia-POLYDENDROCYTE-P2-Tnr|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.67e-05 | 100 | 141 | 5 | 187e31d4186b82a37569b98d83e4813017cc2ddd | |
| ToppCell | mild_COVID-19-pDC|World / disease group, cell group and cell class (v2) | 1.83e-05 | 172 | 141 | 6 | dab2f1a05c7df58d9387b13271b3f1f1583f9ac3 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.95e-05 | 174 | 141 | 6 | 68a6ed81e7e1f95b61f7ee20403980fa3a8db4d0 | |
| ToppCell | droplet-Fat-Bat-18m-Mesenchymal-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.02e-05 | 175 | 141 | 6 | b4f01e7782cdd107d0817ef601891fd3a382bc35 | |
| ToppCell | droplet-Fat-Bat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.02e-05 | 175 | 141 | 6 | ef6f811d8e1839f405c3b41090ddf79be57a099f | |
| ToppCell | droplet-Fat-Bat-18m-Mesenchymal|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.02e-05 | 175 | 141 | 6 | 7f7598d46d10bff1cbea42f950bdde1aaa16e9a4 | |
| ToppCell | Endothelial-B-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 2.08e-05 | 176 | 141 | 6 | b288116a4588a1f9db9d49af92cea118937c9201 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-Proliferating_Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.22e-05 | 178 | 141 | 6 | de6cd81e6d58e7687386df163471bf1901b9c0aa | |
| ToppCell | COVID-19-kidney-Stressed_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.29e-05 | 179 | 141 | 6 | 754f69bac7a1d5137f5141f6193285ccbfe361cb | |
| ToppCell | droplet-Lung-3m-Epithelial-alveolar_epithelial-type_I_pneumocyte-type_1_alveolar_epithelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.29e-05 | 179 | 141 | 6 | ca70a5518c5a5392e088c103e0cb44aa084f5332 | |
| ToppCell | droplet-Lung-3m-Epithelial-alveolar_epithelial-type_I_pneumocyte|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.29e-05 | 179 | 141 | 6 | c451b074b04eb5d6c575c6abaedda579c6744bbf | |
| ToppCell | COVID-19-kidney-PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.36e-05 | 180 | 141 | 6 | 493cf8d1a8f2a1ed2672f394a0338b110fd81d88 | |
| ToppCell | Control-Epithelial_cells-AT2|Control / group, cell type (main and fine annotations) | 2.36e-05 | 180 | 141 | 6 | 198b19e7910b4a8cc7e820c525ab357c7f99f578 | |
| ToppCell | COVID-19-Endothelial_cells-Endothelial_cells_(other)|COVID-19 / group, cell type (main and fine annotations) | 2.44e-05 | 181 | 141 | 6 | 26eb4ee57a70dbf54e096b73129fda9dfda1f6ec | |
| Disease | complex cortical dysplasia with other brain malformations 4 (implicated_via_orthology) | 2.05e-05 | 2 | 134 | 2 | DOID:0090138 (implicated_via_orthology) | |
| Disease | glycine measurement | 3.96e-05 | 137 | 134 | 6 | EFO_0009767 | |
| Disease | chenodeoxycholate measurement | 4.00e-05 | 15 | 134 | 3 | EFO_0010471 | |
| Disease | Disorder of eye | 5.43e-05 | 212 | 134 | 7 | C0015397 | |
| Disease | alkaline phosphatase measurement | NCOA2 WHRN PRKD2 ERMP1 XKR6 ACVR1C GSN ABCA6 NFATC4 GLI3 PCIF1 PRKAR1A DMBT1 CDC42 SMAD7 | 6.07e-05 | 1015 | 134 | 15 | EFO_0004533 |
| Disease | myofibrillar myopathy 5 (implicated_via_orthology) | 6.12e-05 | 3 | 134 | 2 | DOID:0080096 (implicated_via_orthology) | |
| Disease | distal muscular dystrophy 4 (implicated_via_orthology) | 6.12e-05 | 3 | 134 | 2 | DOID:0111190 (implicated_via_orthology) | |
| Disease | triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement | 6.56e-05 | 150 | 134 | 6 | EFO_0004611, EFO_0020947 | |
| Disease | coronary artery disease | PRKD2 SHROOM3 DSCAM CDK12 EFCAB13 MAGI3 SPNS3 PTPRU MSL2 PLEKHG1 SF3B3 PRKAR1A KCNAB1 MCF2L TNS1 SMAD7 | 1.07e-04 | 1194 | 134 | 16 | EFO_0001645 |
| Disease | cortical surface area measurement | NCOA2 PRKD2 DPYSL2 SHROOM3 ANK3 NBL1 TRIM71 ADGRV1 XKR6 STRIP1 TBC1D16 PLEKHG1 GLI3 KCNK10 TNS1 MOV10 PDZD2 | 1.31e-04 | 1345 | 134 | 17 | EFO_0010736 |
| Disease | Ciliopathies | 1.50e-04 | 110 | 134 | 5 | C4277690 | |
| Disease | vital capacity | SHROOM3 CDK12 NBL1 TRIM71 LHX3 AGPS IVD SLC6A1 HMCN1 NFATC4 ACAN GLI3 ROM1 TNS1 MOV10 PDZD2 | 1.59e-04 | 1236 | 134 | 16 | EFO_0004312 |
| Disease | uterine fibroid | 3.06e-04 | 199 | 134 | 6 | EFO_0000731 | |
| Disease | Retinitis pigmentosa | 3.66e-04 | 74 | 134 | 4 | cv:C0035334 | |
| Disease | Colorectal Carcinoma | FLNC DPYSL2 FRMPD2 LAMA1 RBP3 SPNS3 PTPRU ABCA6 GLI3 DCHS1 SMAD7 | 3.73e-04 | 702 | 134 | 11 | C0009402 |
| Disease | basophil count | 3.76e-04 | 483 | 134 | 9 | EFO_0005090 | |
| Disease | non-small cell lung carcinoma | 3.85e-04 | 75 | 134 | 4 | EFO_0003060 | |
| Disease | Disproportionate short stature | 4.26e-04 | 77 | 134 | 4 | C0878659 | |
| Disease | cortical thickness | NCOA2 DPYSL2 SHROOM3 LAMA1 NBL1 ADGRV1 XKR6 SPNS3 PLEKHG1 GLI3 B9D1 KLHL8 TNS1 PDZD2 | 5.55e-04 | 1113 | 134 | 14 | EFO_0004840 |
| Disease | Meckel syndrome (implicated_via_orthology) | 5.63e-04 | 8 | 134 | 2 | DOID:0050778 (implicated_via_orthology) | |
| Disease | creatinine measurement | PRKD2 SHROOM3 IMPDH2 DSCAM CDK12 EPB41L5 LAMA5 LHX3 ADGRV1 CEMIP TBC1D10B OPLAH SMAD7 | 6.20e-04 | 995 | 134 | 13 | EFO_0004518 |
| Disease | free cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 6.47e-04 | 86 | 134 | 4 | EFO_0008595, EFO_0020945 | |
| Disease | red blood cell density measurement | SHROOM3 CDK12 FKBP9 EPB41L5 LHX3 ADGRV1 KCNA4 ZC3H4 PCIF1 PRKAR1B KLHL8 SMAD7 | 6.96e-04 | 880 | 134 | 12 | EFO_0007978 |
| Disease | hematocrit | SHROOM3 EPB41L5 ADGRV1 GSN PLEKHG1 KCNA4 ABCA6 ZC3H4 PRKAR1B EMC10 DMBT1 NOTCH4 SMAD7 | 7.19e-04 | 1011 | 134 | 13 | EFO_0004348 |
| Disease | nephronophthisis (implicated_via_orthology) | 7.22e-04 | 9 | 134 | 2 | DOID:12712 (implicated_via_orthology) | |
| Disease | mitral valve prolapse (is_implicated_in) | 7.22e-04 | 9 | 134 | 2 | DOID:988 (is_implicated_in) | |
| Disease | Anorectal Malformations | 8.60e-04 | 41 | 134 | 3 | C3495676 | |
| Disease | aspartate aminotransferase measurement | WHRN PRKD2 KRT8 SHROOM3 XKR6 KRT79 MSL2 RHOBTB2 KLHL8 CSMD1 MOV10 NOTCH4 | 8.79e-04 | 904 | 134 | 12 | EFO_0004736 |
| Disease | Kunitz-type protease inhibitor 2 measurement | 8.99e-04 | 10 | 134 | 2 | EFO_0008200 | |
| Disease | RETINITIS PIGMENTOSA | 8.99e-04 | 10 | 134 | 2 | 268000 | |
| Disease | plasma trimethylamine N-oxide measurement | 8.99e-04 | 10 | 134 | 2 | EFO_0005691 | |
| Disease | forced expiratory volume | DSCAM CDK12 NBL1 TRIM71 LHX3 IVD SLC6A1 FIG4 NFATC4 ACAN TNS1 | 9.75e-04 | 789 | 134 | 11 | EFO_0004314 |
| Disease | degenerative disc disease (biomarker_via_orthology) | 1.10e-03 | 11 | 134 | 2 | DOID:90 (biomarker_via_orthology) | |
| Disease | myocardial infarction | 1.13e-03 | 350 | 134 | 7 | EFO_0000612 | |
| Disease | Gastrointestinal Stromal Sarcoma | 1.28e-03 | 47 | 134 | 3 | C3179349 | |
| Disease | triacylglycerol 44:1 measurement | 1.31e-03 | 12 | 134 | 2 | EFO_0010399 | |
| Disease | Retinitis Pigmentosa | 1.32e-03 | 104 | 134 | 4 | C0035334 | |
| Disease | phospholipids in medium LDL measurement | 1.45e-03 | 49 | 134 | 3 | EFO_0022183 | |
| Disease | cholesterol in medium LDL measurement | 1.45e-03 | 49 | 134 | 3 | EFO_0022224 | |
| Disease | Gastrointestinal Stromal Tumors | 1.54e-03 | 50 | 134 | 3 | C0238198 | |
| Disease | serum albumin measurement | 1.57e-03 | 592 | 134 | 9 | EFO_0004535 | |
| Disease | total lipids in medium LDL | 1.72e-03 | 52 | 134 | 3 | EFO_0022180 | |
| Disease | response to olanzapine | 2.07e-03 | 15 | 134 | 2 | GO_0097333 | |
| Disease | urate measurement, bone density | 2.13e-03 | 619 | 134 | 9 | EFO_0003923, EFO_0004531 | |
| Disease | low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 2.24e-03 | 200 | 134 | 5 | EFO_0004611, EFO_0020945 | |
| Disease | phospholipids in LDL measurement | 2.35e-03 | 58 | 134 | 3 | EFO_0022294 | |
| Disease | glycochenodeoxycholate measurement | 2.66e-03 | 17 | 134 | 2 | EFO_0010490 | |
| Disease | 1-Methylhistidine measurement | 2.66e-03 | 17 | 134 | 2 | EFO_0021543 | |
| Disease | triglycerides:total lipids ratio, intermediate density lipoprotein measurement | 2.73e-03 | 127 | 134 | 4 | EFO_0008595, EFO_0020947 | |
| Disease | phospholipids:total lipids ratio, high density lipoprotein cholesterol measurement | 2.85e-03 | 307 | 134 | 6 | EFO_0004612, EFO_0020946 | |
| Disease | Tinnitus | 2.97e-03 | 130 | 134 | 4 | HP_0000360 | |
| Disease | age at onset, smoking initiation | 3.33e-03 | 19 | 134 | 2 | EFO_0004847, EFO_0005670 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 3.51e-03 | 222 | 134 | 5 | EFO_0008317, EFO_0020943 | |
| Disease | interstitial lung disease | 3.55e-03 | 67 | 134 | 3 | EFO_0004244 | |
| Disease | Abnormality of refraction | 3.70e-03 | 673 | 134 | 9 | HP_0000539 | |
| Disease | refractive error | 3.83e-03 | 326 | 134 | 6 | MONDO_0004892 | |
| Disease | rheumatoid arthritis (is_marker_for) | 3.86e-03 | 69 | 134 | 3 | DOID:7148 (is_marker_for) | |
| Disease | Joubert syndrome 1 | 4.06e-03 | 21 | 134 | 2 | C4551568 | |
| Disease | bilirubin measurement | 4.16e-03 | 442 | 134 | 7 | EFO_0004570 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SFQGSYVLLVVGGGP | 941 | Q6ZRH7 | |
| GQGLGDSLYATPGLV | 671 | Q8IZF5 | |
| TDYSNLGPVGGGTSG | 111 | O14627 | |
| KLQNYGELGPGTTGA | 1436 | Q9NYV4 | |
| LVSGNLTDRGGPLGY | 486 | Q6UY14 | |
| GGQYTGSEGVVLSPN | 1626 | Q96PZ7 | |
| NTLVGEAGGGLIDYP | 381 | P59827 | |
| YPTLVGLAGGTTSAA | 351 | Q5FYB1 | |
| GTDGLSYNGAIIVSG | 941 | Q8N139 | |
| RPGLYGSVIVAGGNT | 341 | O96019 | |
| IYDVTASGSGSGLPL | 171 | Q8NER5 | |
| ATFPSSGGYGQGSLI | 6236 | Q8WXG9 | |
| SYITGETVVVGGGTP | 261 | Q9BTZ2 | |
| NGIGLTLASGGTFPY | 811 | Q8WUJ3 | |
| SLGNGTPVTSKGGDY | 816 | Q7Z2K6 | |
| GLYTGEVTEIVGGPG | 96 | O75771 | |
| GYLSPDILLEGSGNG | 1706 | O95153 | |
| TTGGPGDDYGVLGST | 126 | P50221 | |
| VLNTNGTSGFLPGGY | 26 | Q9UKR3 | |
| GGLSSAYGGLTSPGL | 421 | P05787 | |
| SLSTIGLGDYVPGEA | 211 | Q9Y257 | |
| YVTRGPQTGGISGLD | 391 | Q9UM07 | |
| SSVVAGYGSPGQKGT | 381 | Q14728 | |
| GGGPISSILVNKYGS | 71 | P53985 | |
| EGENGTILYTLTGPG | 1246 | Q96JQ0 | |
| GVGALTYTLVGGADP | 1361 | Q96JQ0 | |
| GGTNGPITYSILSGN | 2096 | Q96JQ0 | |
| RSGPAGGYQTLGENS | 1206 | P10071 | |
| YVGIGLPGLSFGSEG | 586 | Q2Q1W2 | |
| LGGDGPDQSIYIGAI | 741 | Q5TCQ9 | |
| GTVVYGEPITASLGT | 271 | Q16555 | |
| VSKGAYAGITGNPSG | 81 | Q9HC44 | |
| QPGLSRGQDGYSGET | 946 | O60303 | |
| GIISGKYGNGVPESS | 301 | Q14722 | |
| ISGGTSYVPDDGLTA | 6 | P12268 | |
| GYSTVKGGPVSAGTS | 506 | Q5XKE5 | |
| STTGYGHTVPLSDGG | 116 | O00180 | |
| GLSSTYTGGPLGNEI | 16 | Q9Y6G9 | |
| PDQREIISFGSGYGG | 241 | Q16822 | |
| LGGPIYAIGGLDDNT | 411 | Q9P2G9 | |
| GGLPSLANGQGIYSV | 2266 | O15018 | |
| YGGLGLSIEGPSKVD | 2071 | Q14315 | |
| GLVSAYGPGLEGGTT | 2506 | Q14315 | |
| YGPGLEGGTTGVSSE | 2511 | Q14315 | |
| EGEGGKAQSSLGYIP | 366 | Q9BZL6 | |
| GLYGSLGEPTQALGR | 271 | Q9UBR4 | |
| TTIGYGNIAPSTEGG | 166 | P57789 | |
| IGGEPYTLGLFDTAG | 46 | P60953 | |
| LGGLPESGTIYNFSG | 3246 | O15230 | |
| GLSVYVQGEDGPGSQ | 131 | P41271 | |
| GVLGITAPVQYGGSG | 91 | P26440 | |
| IGSSVINGLPTYNGL | 186 | Q9HCI7 | |
| EGPVGSTLGSYATLT | 816 | Q8WXE0 | |
| EILQAVGGGPGTGSY | 241 | Q09013 | |
| KQYGLGPNGGIVTSL | 81 | Q9HCN4 | |
| VGGGETYTIGLQFAP | 1381 | O75161 | |
| GQPGISGEASGVLYG | 1761 | P16112 | |
| GGGYVVPLGTDRQST | 2101 | Q7Z442 | |
| GADGSLYVVSPGGEE | 1031 | Q96RW7 | |
| ISGGTGYVPEDGLTA | 6 | P20839 | |
| TLGVYVRVNGGPLGS | 116 | Q92729 | |
| QTPSVYDESGSTGGG | 21 | Q96RI0 | |
| YGEEGRGNIPGSAVL | 341 | O95302 | |
| SPITELLEQNGGYGS | 326 | O14976 | |
| GAEPGTYLTGTINGD | 121 | O75173 | |
| DGNDYSLGLTPTGVL | 241 | Q9HCM4 | |
| QLDTEGVGSLGPGYE | 361 | Q969P0 | |
| VGLYEGTGLQGSLPV | 481 | Q9H4Z3 | |
| QGSGGYSLEIGSLAA | 436 | Q96AV8 | |
| IDYQGRPSGGFVISG | 756 | Q03188 | |
| SRSQYQGGGLVSEPG | 241 | Q96MA1 | |
| VTCLYPGGGSSTLTG | 626 | Q9P218 | |
| TQGGSGVFGICSEPY | 211 | Q92562 | |
| GYGGLSLSIEGPSKV | 2076 | P21333 | |
| GFSVTGGINTSVPYG | 961 | Q68DX3 | |
| GASLEGSQVYLGLSP | 166 | Q8NBF6 | |
| SGEGVSNGYKGDTTP | 1226 | Q12955 | |
| GGVGSSNVGVQEPYS | 371 | Q8IY85 | |
| AYLSGGRGQDGSPVI | 81 | O15068 | |
| YLGHEGPGGAVSTSQ | 46 | Q6PJG2 | |
| FTIPLSGYGGTSNLI | 1871 | Q8TEP8 | |
| EGGSFGELALIYGTP | 196 | P10644 | |
| EGGSFGELALIYGTP | 196 | P31321 | |
| IYKGGTSREGGQTAP | 546 | P06396 | |
| PGALDGLEAGGYVSS | 116 | Q5UCC4 | |
| LGYDTGPSDTQGVLG | 181 | Q9UPM9 | |
| ATEAGGGNPSGIYSA | 31 | P20807 | |
| LGNAYFGSGSGPITL | 1936 | Q9UGM3 | |
| SQAPYGTLGAVSGGE | 36 | Q5VV67 | |
| LNDTYSLGPLGSGGF | 231 | Q8WY07 | |
| GTATLENGSGPGLYV | 36 | Q3SX64 | |
| PGDNGGSSIRGYILQ | 1401 | O60469 | |
| LPDTYGFQGSAGGLS | 166 | Q12946 | |
| LDGNTEPGLTLGGYF | 276 | Q6P1K8 | |
| SGSRGGGVVPYLGTF | 421 | O15211 | |
| AGAGDLTGDPIGYVT | 146 | Q5M8T2 | |
| VYLFGGLGTSSSPVG | 296 | Q06945 | |
| ECSLGQYTSIGGLGV | 101 | P30531 | |
| GTGGVSIYGETFPDE | 106 | P45877 | |
| LEGSGSYNKGSGVPD | 71 | A0A075B6I1 | |
| GGYSSGFRDSVPIQG | 861 | Q14934 | |
| PGESGSEGAGTFYIA | 221 | Q9HCE1 | |
| GYVPGLGRGATGFTT | 16 | O94906 | |
| VLSGPAGGVVGYSAT | 286 | O14841 | |
| GRGSYGDLGGPIITT | 376 | P61978 | |
| SNLYVGGIPEGEGTS | 2621 | P25391 | |
| TSDGILRGNGTGYLP | 366 | Q9BYZ6 | |
| ILQGYGDGQGPVTDT | 21 | Q6ZNE9 | |
| GYTLGSDTNTVVGLP | 446 | Q5VSL9 | |
| TGAQGAGVELYPGSI | 526 | Q9BZQ2 | |
| PYGTGLGQRTGQVTV | 421 | Q2M3G4 | |
| SSLELGRGTQEGYPG | 676 | Q8TF72 | |
| GLGIYITGVDPGSEA | 301 | Q9P202 | |
| GGQVLSEYTGPTSAD | 486 | Q8NCN4 | |
| YTPTGYGTLVQEGGS | 156 | P55809 | |
| LYNGSCSETTGLGGP | 1141 | Q99466 | |
| CIIPIGGGTSVSYGL | 231 | O00116 | |
| GQGSYETIGPLSEGD | 31 | Q9HAW4 | |
| FGLYGEPSEGTTGQA | 586 | Q15596 | |
| QDYTGGGLGAVEGLT | 186 | Q5GH73 | |
| SSAETGGTNYLAPGG | 231 | O15105 | |
| GGTNYLAPGGLSDSQ | 236 | O15105 | |
| PTAGGALSVGIYQVG | 871 | P10745 | |
| QRAGYGGTGSIEIPV | 211 | Q9NZQ8 | |
| GDAGSPYLTGLISSV | 416 | Q6ZMD2 | |
| DAGGETQGYLFPSGL | 301 | Q03395 | |
| IAGGTGSGLGSYLLE | 141 | P23258 | |
| LDGNTEPGLTLGGYF | 276 | Q13888 | |
| GYSGLATGNGLSDSP | 101 | A7XYQ1 | |
| TVYSGALGTPGAAGS | 341 | Q6NTF9 | |
| GSGSPSVLDGEIIYS | 26 | Q8TBP0 | |
| SLDGVTNTSEGGYPE | 521 | Q9HBL0 | |
| SGGEPLSQGAGSYVV | 406 | P20061 | |
| GSTFLQTEGGRTGPY | 86 | O75631 | |
| GGSQYSGSLESSIPV | 311 | Q4KMP7 | |
| GTTLVITGNGFYPGN | 1846 | Q86WI1 | |
| PGGSESLVYTTLSGG | 1111 | Q15393 | |
| GGGQSSVLSGISLYD | 1136 | Q9UPT8 | |
| IAGGTGSGLGSYLLE | 141 | Q9NRH3 | |
| GSLYAQTDGTLSGGE | 711 | Q9ULL1 | |
| GNIPSEASGLYKGGE | 196 | Q5T0J7 | |
| IPEGFGLTSGGSNYS | 1156 | Q9Y4E6 | |
| YGVASSVGTIQGAGP | 106 | Q3YBR2 | |
| SPVLSGGYVLGGGAI | 336 | Q7Z7E8 | |
| ETYGNLVSLGVGPAG | 66 | Q8IZ26 | |
| LDGQTEGTGAISGYP | 71 | P22415 | |
| LLPQDEGGGGYSSVR | 156 | P22459 | |
| GALNVSYSIGPGFTG | 311 | Q9Y3Q0 |